Trimethoprim/Sulfamethoxazole Combined With Caspofungin as First-line Therapy in PCP

Pneumocystis Pneumonia Clinical Trial

Official title:
A Prospective Randomized Controlled Study to Compare Efficacy of Caspofungin Combined With Trimethoprim-sulfamethoxazole Versus Trimethoprim/Sulfamethoxazole as First-line Therapy in Non-HIV Patients With Severe Pneumocystis Pneumonia

Status Recruiting

Clinical Trial Summary

This is a prospective, randomized clinical trial. During the study, non-HIV patients who are admitted to ICU due to Pneumocystic pneumonia (PCP) and have not received anti-PCP therapy or have received therapy less than 48hrs will be randomized (1:1) to received caspofungin combined with trimethoprim-sulfamethoxazole or trimethoprim-sulfamethoxazole alone.

The aim of this study is to compare the effectiveness of caspofungin combined with trimethoprim-sulfamethoxazole with that of conventional therapy (trimethoprim-sulfamethoxazole alone) as first-line therapy in the treatment of severe Pneumocystis pneumonia (PCP) in non-HIV patients.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03978559
Study type	Interventional
Source	Peking Union Medical College Hospital
Contact	Bin Du
Phone	0086-10-69155036
Email	dubin98@gmail.com
Status	Recruiting
Phase	Phase 4
Start date	August 14, 2019
Completion date	July 8, 2022

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT02603575` - Effects and Safety of Caspofungin and Corticosteroids in Pneumocystis Pneumonia in Non-HIV Patients	N/A
Recruiting	`NCT05835479` - Rezafungin for Treatment of Pneumocystis Pneumonia in HIV Adults	Phase 2
Recruiting	`NCT05605145` - PCP in Immunocompromised Population in Southern China
Completed	`NCT03087890` - Impact of Cotrimoxazole Use in Immunocompetent HIV Patients on Carriage of Antimicrobial Resistant Bacteria	Phase 4
Completed	`NCT05077150` - A Case-control Study on Risk Factors, Timing, and PCR Use, for Pneumocystis Pneumonia (PcP) After Allogeneic HSCT
Not yet recruiting	`NCT04851015` - Low Dose Trimethoprim-Sulfamethoxazole for the Treatment of Pneumocystis Jirovecii Pneumonia	Phase 3
Recruiting	`NCT02550080` - Clinical Utility Of Genetic Screening For HLA-B*1301, On Susceptibility To Dapsone Hypersensitivity Syndrome	Phase 4
Completed	`NCT00869544` - Pneumocystis in Pathogenesis of HIV-associated Emphysema
Completed	`NCT04358419` - Non-invasive Diagnosis of Invasive Pulmonary Aspergillosis by Use of Biomarkers in Exhaled Breath Condensate